Clinical trials
Thrombosis trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
54 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 1 |
| 2006 | 4 |
| 2007 | 1 |
| 2008 | 2 |
| 2009 | 5 |
| 2010 | 3 |
| 2011 | 3 |
| 2012 | 4 |
| 2013 | 3 |
| 2014 | 1 |
| 2015 | 3 |
| 2016 | 1 |
| 2017 | 1 |
| 2018 | 3 |
| 2019 | 4 |
| 2020 | 2 |
| 2021 | 3 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 39 |
| Unknown status | 10 |
| Terminated | 2 |
| Active, not recruiting | 1 |
| Not yet recruiting | 1 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Bayer | 7 |
| Boston Scientific Corporation | 3 |
| Bristol-Myers Squibb | 3 |
| Sanofi | 3 |
| Alexion Pharmaceuticals, Inc. | 2 |
| Doasense GmbH | 2 |
| Johann Wolfgang Goethe University Hospital | 2 |
| AdvanceCor GmbH | 1 |
| Astellas Pharma Europe B.V. | 1 |
| AstraZeneca | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Thrombosis | 54 |
| Embolism | 9 |
| Pulmonary Embolism | 9 |
| Venous Thrombosis | 9 |
| Cardiovascular Diseases | 8 |
| Stroke | 8 |
| Venous Thromboembolism | 8 |
| Thromboembolism | 6 |
| Ischemic Stroke | 4 |
| Myocardial Infarction | 4 |
Trials
Showing 51 to 54 of 54. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.